Call for Abstract
18thWorld Congress on Vascular Dementia and Neurodegenerative Diseases, will be organized around the theme “”
Vascular Dementia Congress 2023 is comprised of keynote and speakers sessions on latest cutting edge research designed to offer comprehensive global discussions that address current issues in Vascular Dementia Congress 2023
Submit your abstract to any of the mentioned tracks.
Register now for the conference by choosing an appropriate package suitable to you.
Dementia is often incorrectly referred to as "senility" or "senile dementia," which reflects the formerly widespread but incorrect belief that serious mental decline is a normal part of aging.
Dementia is a syndrome – usually of a chronic or progressive nature – in which there is deterioration in cognitive function (i.e. the ability to process thought) beyond what might be expected from normal ageing. It affects memory, thinking, orientation, comprehension, calculation, learning capacity, language, and judgement. Consciousness is not affected. The impairment in cognitive function is commonly accompanied, and occasionally preceded, by deterioration in emotional control, social behaviour, or motivation.
Early stage: the early stage of dementia is often overlooked, because the onset is gradual.
Late stage: the late stage of dementia is one of near total dependence and inactivity. Memory disturbances are serious and the physical signs and symptoms become more obvious.
• Moderate Cognitive Decline
• Severe Cognitive Decline (Middle Dementia)
• Functional Assessment Staging (FAST)
<p background-color:="\"\"" font-size:="\"\"" roboto="\"\"" style="\"box-sizing:" border-box;="" margin:="" 0px="" 10px;="" color:="" rgb(51,="" 51,="" 51);\"="" text-align:="\"\""> • Clinical Dementia Rating (CDR) – No dementia, Moderate, Mild, Severe.
<p 0px="" background-color:="" color:="" follow="" font-family:="" font-size:="" inability="" margin:="" n="" p="" roboto="" box-sizing:"="" text-align:="" to="">
Amyloid imaging is a technique performed in nuclear medicine. It uses PET ligands that allow in vivo detection of amyloid plaques, a core pathologic feature of Alzheimer disease and dementia.
The Immunotherapy treats the Immune system in Injury and repair during wide range of Neurological disorders, Inflammatory and Autoimmune Diseases of the Nervous system such as Multiple Sclerosis (MS) and Neuromyelitis Optical (NMO) and several Brain Tumor conditions. There were numerous Radiological studies to improve Diagnosis and treatment of these diseases. The main focus is to develop the so-called Neuroprotective (nerve cell protecting) treatment approaching and establishing Modern examination procedures such as MRI (Magnetic Resonance Imaging), OCT (Optical Coherence Tomography) and Motion Analysis.
Neuroradiology uses primary imaging modalities including computed tomography (CT) and magnetic resonance imaging (MRI) to focus on Endovascular or minimally invasive diagnosis and characterization of abnormalities of the Central Nervous System or head and neck lesions such as Tumors, Aneurysms, Vascular malformations, or Stroke. It involves different types of Imaging Studies like Computed Tomography (CT) and Magnetic Resonance Imaging (MRI) for characterization of various Neurological disorders.
Neurotoxicity is considered as a major cause of neurodegenerative disorders. Most drugs of abuse have non-negligible neurotoxic impacts a significant number of which are essentially interceded by a few dopaminergic and glutamatergic neurotransmitter frameworks. Neurotoxicity and formative neurotoxicities are imperative antagonistic wellbeing impacts of several ecological contaminants and word related synthetic substances, regular poisons and pharmaceutical medications.
Alzheimer’s is a neurological cerebrum issue. This Alzheimer’s sickness is the most widely recognized type if dementia, the gathering of scatters that will disable the mind working. Memory loss is the most punctual indications for this disease, reduces the thinking capacities and changes in identity or contact. Thus, Vascular Dementia 2019 may give helpful focuses to the Alzheimer’s sickness and detail part of neurological science.
Age-related memory impairment and dementia can be stated apart in several ways. Also, in adults younger than 60 will be affected rare with dementia, but dementia becomes increasingly common after 60 ages. Understanding the back-and-forth between psychology and brain changes is a vital step in the direction of improving how we age and auxiliary to healthy ageing in society. The Vascular Dementia 2019 aims to describe how our inward lives changes as we age, both as healthy and disease.
A diagnosis of dementia entails that at least two core mental purposes be lessened enough to affect with daily existing. Cognitive and Neuropsychological tests can be used to measure thinking skills. The memory treatment has been designated great significances for patients with dementia. The neurological evaluation is the treatment for problem-solving, visual perception and movement. Brain scans are like CT or MRI and PET scans are shows the patters of the brain activity if the amyloid protein had been deposited in the brain. The Conference on Vascular Dementia 2019 has taken one segment closer to dementia therapy.